The pharmacists fighting high drug prices

We look at three solutions connected to the “three Rs” – reduce, reuse and recycle. The city of Brussels in Belgium is in the process of moving all 40 municipal nurseries over to reusable nappies – and have managed to do it without their staff kicking up a stink! Also energy comp ...  Show more

Myra Anubi looks at two solutions that harness the power of pictures to help disabled people. Books Beyond Words is a UK charity that publishes books with no words, just big pictures on every page. They are made for people with learning disabilities, who come together to read the ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

High prescription costs are a major barrier to the optimal treatment of many health conditions. Prescribers need tools to help patients find the lowest drug costs. Author Hussain S. Lalani, MD, MPH, MSc, of Brigham and Women's Hospital and Harvard Medical School joins JAMA Sen ...

John Green recently made a video asking Johnson & Johnson not to extend their patent on a tuberculosis drug, which would keep it exclusive and expensive. Dr. Sydnee and Justin talk about how drug patents work, the recent (good) update about bedaquiline specifically, and the ne ...

Gilead Sciences announced today that it will charge the U.S. government and other developed countries $390 per vial for its coronavirus-fighting drug remdesivir. That begins to answer a big question as drug companies race to find treatments and develop vaccines for the virus: How ...  Show more